LINC00665 promotes Ovarian Cancer progression through regulating the miRNA-34a-5p/E2F3 axis

被引：16

作者：

Xu, Dan ^{[1
,3
]}

Song, Qingxia ^{[1
]}

Liu, Ying ^{[1
]}

Chen, Wansu ^{[1
]}

Lu, Lijuan ^{[1
]}

Xu, Min ^{[1
]}

Fang, Xiaohui ^{[4
]}

Zhao, Wenjie ^{[1
]}

Zhou, Huifang ^{[2
,3
]}

机构：

[1] Nanjing Univ Chinese Med, Dept Gynaecol, Suzhou TCM Hosp, Suzhou 215009, Peoples R China

[2] Nanjing Univ Chinese Med, Dept Gynaecol, Affiliated Hosp, Nanjing 210029, Peoples R China

[3] Nanjing Univ Chinese Med, Nanjing 210023, Peoples R China

[4] Nanjing Univ Chinese Med, Dept Clin Lab, Suzhou TCM Hosp, Suzhou 215009, Peoples R China

来源：

JOURNAL OF CANCER | 2021年 / 12卷 / 06期

关键词：

ovarian cancer; LINC00665; miRNA-34a-5p; E2F3;

D O I：

10.7150/jca.51457

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objective: To clarify the role of LINC00665 in ovarian cancer (OC) progression and the possible mechanism. Methods: LINC00665 levels in OC tissues and cell lines were detected by qRT-PCR. The correlation between LINC00665 and clinicopathologic characteristics of OC patients was assessed. Biological functions of OC cell phenotypes influenced by LINC00665 were examined by CCK-8, colony formation and Transwell assay. Dual-luciferase reporter assay and RIP assay were conducted to verify the interaction between LINC00665 and its downstream target. Results: LINC00665 was upregulated in OC and linked to poor prognosis. Knockdown of LINC00665 blocked malignant proliferative, migratory and invasive functions of OC cells. By competitively binding miRNA-34a-5p, LINC00665 abolished the inhibitory effect of miR-34a-3p on its downstream gene E2F3, thus promoting OC progression. Conclusion: LINC00665/miRNA-34a-5p/E2F3 axis is involved in OC progression, providing novel insights into the clinical treatment of OC.

引用

页码：1755 / 1763

页数：9

共 50 条

[41] RETRACTED: LINC00665 Promotes the Progression of Multiple Myeloma by Adsorbing miR-214-3p and Positively Regulating the Expression of PSMD10 and ASF1B (Retracted Article)
Wang, Chong
Li, Mengya
Wang, Shujuan
Jiang, Zhongxing
Liu, Yanfang
ONCOTARGETS AND THERAPY, 2020, 13 : 6511 - 6522
[42] LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p/e2f2 axis
Li, Zhen
Lang, Zhiqiang
Wang, Ting
Qu, Guimei
Sui, Wu
Liu, Jing
CELL CYCLE, 2023, 22 (03) : 347 - 360
[43] Long noncoding RNA LINC00858 promotes the progression of ovarian cancer via regulating the miR-134-5p/TRIM44 axis
Li, Pengbo
Huang, Gang
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2022, 42 (04) : 382 - 389
[44] LncRNA LINC00461 Promotes Colorectal Cancer Progression via miRNA-323b-3p/NFIB Axis
Yu, Hairong
Ma, Jianguo
Chen, Jianshuang
Yang, Yang
Liang, Jianjing
Liang, Yulong
ONCOTARGETS AND THERAPY, 2019, 12 : 11119 - 11129
[45] LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis
Lu, Mingming
Gao, Qing
Wang, Yafei
Ren, Jie
Zhang, Tingting
APOPTOSIS, 2022, 27 (11-12) : 800 - 811
[46] LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis
Mingming Lu
Qing Gao
Yafei Wang
Jie Ren
Tingting Zhang
Apoptosis, 2022, 27 : 800 - 811
[47] LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis
Jindun Pan
Yunhong Zang
Digestive Diseases and Sciences, 2022, 67 : 2936 - 2947
[48] LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis
Pan, Jindun
Zang, Yunhong
DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 2936 - 2947
[49] LINC00649 promotes bladder cancer malignant progression by regulating the miR-15a-5p/HMGA1 axis
Chen, Xuanyu
Chen, Song
ONCOLOGY REPORTS, 2021, 45 (04)
[50] E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B
Liu, Guodong
Ouyang, Xiwu
Gong, Liansheng
Yao, Lei
Liu, Shiqing
Li, Jiarong
Zhang, Qi
Xiao, Yao
MOLECULAR THERAPY NUCLEIC ACIDS, 2021, 26 : 104 - 113

← 1 2 3 4 5 →